Discovery Outsourcing Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the drug discovery outsourcing market heading? If you are involved in this sector you must read this newly updated report. The report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 490-page report provides 327 tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Drug Discovery Outsourcing Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

Drug Discovery Outsourcing Market: By Service Type

  • Chemistry Services
  • Biology Services
  • Lead Identification & Screening Services
  • Lead Optimisation Services

Drug Discovery Outsourcing Market: By Molecule Type

  • Large Molecule Drugs
  • Small Molecule Drugs

Drug Discovery Outsourcing Market: By Therapeutic Area

  • Oncology
  • Infectious Disease
  • Central Nervous System
  • Immunology
  • Cardiovascular Disease
  • Metabolic Disease
  • Respiratory Disease
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:

North America

  • U.S.
  • Canada


  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the drug discovery outsourcing market, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
Overall world revenue for Drug Discovery Outsourcing Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Drug Discovery Outsourcing Market report helps you
In summary, our 490-page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Drug Discovery Outsourcing Market, with forecasts for Service Type, Molecule Type, and Therapeutic Area, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the drug discovery outsourcing market in North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market– including company profiles for 20 of the major companies involved in the Drug Discovery Outsourcing Market. Some of the company’s profiled in this report include Evotec, GVK Bio, Charles River Laboratories, LabCorp, Domainex Ltd, Genscript Biotech Corporation, Jubilant Biosys Ltd – Gilead Sciences, Viva Biotech, WuXi AppTec, Dalton Pharma, Eurofins, and Syngene, Selvita.